Evidence map›Paper›PMID 24458430›Full record

ArticleEuropean journal of immunology2014

Recognition of Salmonella by Dectin-1 induces presentation of peptide antigen to type B T cells.

Nicola Jackson, Evan Compton, John Trowsdale, Adrian P Kelly

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Nicola JacksonDivision of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK.
Evan Compton
John Trowsdale
Adrian P Kelly
Bridge University · SSCambridge School · PT

Funding

Wellcome Trust 100140
6 · The paper itself

Abstract

Type B T cells recognize peptide-MHC class II (pMHCII) isoforms that are structurally distinct from those recognized by conventional type A T cells. These alternative type B conformers result from peptide loading in the absence of HLA-DM. Type A conformers are more stable than type B pMHCII conformers but bind the same peptide in the same register. Here, we show that interaction of Salmonella Typhimurium with bone marrow derived dendritic cells (BMDCs) isolated from C3H/HeNCr1 mice results in enhanced presentation of peptide Ag to type B T cells. The effect could be mimicked by purified PAMPs, the most potent of which were curdlan and zymosan, β-(1,3)-glucan-containing polymers that are recognized by Dectin-1. Blocking of Dectin-1 with Ab and laminarin inhibited the induction of the type B T-cell response by BMDCs, confirming its role as a PRR for S. Typhimurium. Splenic DCs (sDCs) expressed Dectin-1 but were refractive to the induction of type B responses by S. Typhimurium and curdlan. Type B T cells have been shown to escape thymic tolerance and to transfer pathology in an autoimmune disease model. The induction of type B responses by gram-negative bacteria provides a mechanism by which autoreactive T cells may be produced during infection.

Indexed as

AnimalsAntigen PresentationAntigens, BacterialB7-1 Antigenbeta-GlucansBone Marrow CellsCells, CulturedDectin-1Dendritic CellsFlow CytometryHistocompatibility Antigens Class IIHost-Pathogen InteractionsLectins, C-TypeLipopolysaccharidesMiceMice, Inbred C3HAntigens, BacterialB7-1 Antigenbeta-GlucanscurdlanDectin-1Histocompatibility Antigens Class IILectins, C-TypeLipopolysaccharidesPeptidesAntigen presentationAutoimmunityBacterial infection

Identifiers

PMID24458430
PMCPMC4282065
OpenAlexW1495927492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.